Development of cancer prophylaxis may be the most realistic option for improving mortality associated with this disease. Here, we develop a novel individualized prophylactic and therapeutic vaccination regimen using induced pluripotent stem cells (iPSC), gene editing, and tumor-targeted replicating oncolytic viruses. Read more . . .
Pancreatic cancer remains one of the most lethal cancers, and late detection renders most tumors refractory to conventional therapies.